Q2 2015 Holdings
Filed 2015-08-13 | 27 holdings | $32.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $25.2M | 870,269 | 77.0% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $5.6M | 373,686 | 17.1% |
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $1.6M | 811,152 | 4.9% |
| Anacor Pharmaceuticals Inc | COM | 032420101 | $91.2K | 1,178,474 | 0.3% |
| GW Pharmaceuticals | COM | 36197T103 | $38.3K | 311,853 | 0.1% |
| DBV Technologies | COM | F2927N109 | $37.1K | 693,810 | 0.1% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $34.1K | 1,095,734 | 0.1% |
| Avalanche Biotechnologies Inc | COM | 05337G107 | $22.5K | 1,382,735 | 0.1% |
| Zafgen Inc | COM | 98885E103 | $18.8K | 541,480 | 0.1% |
| Arca biopharma Inc | COM | 00211Y100 | $12.4K | 10,789,324 | 0.0% |
| Lipocine Inc | COM | 53630X104 | $10.9K | 1,269,921 | 0.0% |
| Flamel Technologies S.A. | COM | 338488109 | $10.6K | 500,000 | 0.0% |
| Alcobra Ltd | COM | M2239P109 | $9.8K | 1,500,000 | 0.0% |
| Cynapsus Therapeutics Inc | COM | 23257Y701 | $5.9K | 367,427 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $5.3K | 451,400 | 0.0% |
| ZS Pharma Inc | COM | 98979G105 | $5.2K | 100,000 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $4.8K | 90,206 | 0.0% |
| Ocera Therapeutics | COM | 67552A108 | $2.7K | 703,730 | 0.0% |